Kovacs Shane William Charles
Chief Financial Officer
Avg. Two Year Performance
No Purchase Track Record
77% Avg. Sale Return
33% Compound
Holdings: 37.85K shares
Last Three Months: 16-Feb-24 -- 15-May-24
Sentiment
Company Sentiment
Biotechnology
Drugs
Two Year Chart
16-May-22 -- 15-May-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions